private:synthelis
|
663241
|
Jun 3rd, 2019 12:00AM
|
SYNTHELIS
|
703
|
9.00
|
Open
|
Biotechnology
|
Jun 3rd, 2019 05:14PM
|
Jun 3rd, 2019 05:14PM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
Open
|
protein identification, protein characterization, protein production, protein delivery, cell-free, antibody development, vaccine development, screening, display technology, in vitro diagnostics, structural biology, protein in detergent, protein in proteoliposome
|
Open
|
BIOPOLIS, 5 Avenue du Grand Sablon
|
La Tronche
|
|
FR
|
38700
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 17th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 16th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 15th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 14th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 13th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 12th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 11th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 10th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:synthelis
|
663241
|
Feb 9th, 2018 12:00AM
|
SYNTHELIS
|
494
|
8.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening.
|
|
|
|
|
|
|
|
|
|
Synthelis
|
Health Care
|
Pharmaceuticals & Biotechnology
|